Actively Recruiting
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
Led by New York University · Updated on 2025-11-21
80
Participants Needed
1
Research Sites
225 weeks
Total Duration
On this page
Sponsors
N
New York University
Lead Sponsor
N
National Institute of Dental and Craniofacial Research (NIDCR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective study involving human participants. Pressure and stretch sensitivity measures between oral cancer patients and healthy subjects will be compared. Pain stimulation will be conducted on the site of the cancer in 40 oral cancer patients, and on the tongue in 40 healthy volunteers, using pressure and stretch sensitivity tests.
CONDITIONS
Official Title
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
For healthy subjects to be eligible to participate in this study, an individual must meet all of the following criteria:
- Provide signed and dated informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
- Male or female, at least 18 years of age
- In good general health as evidenced by medical history
For oral cancer patients to be eligible to participate in this study, an individual must meet all of the following criteria:
- Provide signed and dated informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
- Male or female, at least 18 years of age
- Biopsy-proven squamous cell carcinoma (SCC) of the oral cavity that requires surgical resection
- Lesion is at least 1 cm in greatest surface dimension
You will not qualify if you...
-
Healthy subjects who meet any of the following criteria will be excluded from participation in this study:
- Clinically and/or histologically proven oral pre-cancer, oral cancer
- Pregnancy or lactation (Female subjects of child-bearing potential will have a rapid urine pregnancy test)
- Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.
Oral cancer patients who meet any of the following criteria will be excluded from participation in this study:
- History of prior surgical, chemotherapeutic, or radiation treatment for head and neck cancer
- Pregnancy or lactation
- Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.
For participants with impaired kidney function (chronic kidney/renal disease) who wish to participate in the proposed research study, consultation with their primary care provider will be done prior to enrollment to determine safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU College of Dentistry
New York, New York, United States, 10010
Actively Recruiting
Research Team
Y
Yatendra Mulpuri, PhD
CONTACT
M
Mariana Bucovsky, MHA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here